REGENEREX PHARMA, INC. (RGPX)
2025-06-30 | ||||
|---|---|---|---|---|
| Operating loss | -633,783 | |||
| Interest expense | 23,596 | |||
| Taxes | -113 | |||
| Foreign currency gain (loss) | -6,092 | |||
| Total other income (expenses | -29,801 | |||
| Net loss | -663,584 | |||
| Weighted average number of common shares outstanding | 281,123,410 | |||